{"id":"https://openalex.org/W1995384373","doi":"https://doi.org/10.1124/jpet.106.116467","title":"Apomine Enhances the Antitumor Effects of Lovastatin on Myeloma Cells by Down-Regulating 3-Hydroxy-3-methylglutaryl-Coenzyme A Reductase","display_name":"Apomine Enhances the Antitumor Effects of Lovastatin on Myeloma Cells by Down-Regulating 3-Hydroxy-3-methylglutaryl-Coenzyme A Reductase","publication_year":2007,"publication_date":"2007-04-06","ids":{"openalex":"https://openalex.org/W1995384373","doi":"https://doi.org/10.1124/jpet.106.116467","mag":"1995384373","pmid":"https://pubmed.ncbi.nlm.nih.gov/17412884","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2820734"},"language":"en","primary_location":{"id":"doi:10.1124/jpet.106.116467","doi":"https://doi.org/10.1124/jpet.106.116467","is_oa":false,"landing_page_url":"https://doi.org/10.1124/jpet.106.116467","pdf_url":null,"source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2820734","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066862424","display_name":"Anke J. Roelofs","orcid":"https://orcid.org/0000-0001-8993-1984","observed_orcids":["https://orcid.org/0000-0001-8993-1984"]},"institutions":[{"id":"https://openalex.org/I195460627","display_name":"University of Aberdeen","ror":"https://ror.org/016476m91","country_code":"GB","type":"education","lineage":["https://openalex.org/I195460627"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Anke J. Roelofs","raw_affiliation_strings":["Bone Research Group, Institute of Medical Sciences, Foresterhill, Aberdeen AB25 2ZD, UK. a.roelofs@abdn.ac.uk","Bone Research Group, Institute of Medical Sciences, Foresterhill, Aberdeen AB25 2ZD, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bone Research Group, Institute of Medical Sciences, Foresterhill, Aberdeen AB25 2ZD, UK. a.roelofs@abdn.ac.uk","institution_ids":["https://openalex.org/I195460627"]},{"raw_affiliation_string":"Bone Research Group, Institute of Medical Sciences, Foresterhill, Aberdeen AB25 2ZD, UK","institution_ids":["https://openalex.org/I195460627"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018583564","display_name":"Claire M. Edwards","orcid":"https://orcid.org/0000-0002-1257-5659","observed_orcids":["https://orcid.org/0000-0002-1257-5659","https://orcid.org/0009-0004-4542-2386"]},"institutions":[{"id":"https://openalex.org/I195460627","display_name":"University of Aberdeen","ror":"https://ror.org/016476m91","country_code":"GB","type":"education","lineage":["https://openalex.org/I195460627"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I74680897","display_name":"Procter & Gamble (United States)","ror":"https://ror.org/04dkns738","country_code":"US","type":"company","lineage":["https://openalex.org/I74680897"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Claire M. Edwards","raw_affiliation_strings":["Botnar Research Centre, Nuffield Department of Orthopaedic Surgery, University of Oxford, Oxford, United Kingdom (A.J.R., P.A.H., R.G.G.R.); Bone Research Group, Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, United Kingdom (A.J.R., M.J.R.); Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee (C.M.E.); and Procter and Gamble Pharmaceuticals, Cincinnati, Ohio (F.H.E.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Botnar Research Centre, Nuffield Department of Orthopaedic Surgery, University of Oxford, Oxford, United Kingdom (A.J.R., P.A.H., R.G.G.R.); Bone Research Group, Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, United Kingdom (A.J.R., M.J.R.); Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee (C.M.E.); and Procter and Gamble Pharmaceuticals, Cincinnati, Ohio (F.H.E.)","institution_ids":["https://openalex.org/I195460627","https://openalex.org/I40120149","https://openalex.org/I74680897","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068713744","display_name":"R.G.G. Russell","orcid":"https://orcid.org/0000-0002-4136-1828","observed_orcids":["https://orcid.org/0000-0002-4136-1828"]},"institutions":[{"id":"https://openalex.org/I195460627","display_name":"University of Aberdeen","ror":"https://ror.org/016476m91","country_code":"GB","type":"education","lineage":["https://openalex.org/I195460627"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I74680897","display_name":"Procter & Gamble (United States)","ror":"https://ror.org/04dkns738","country_code":"US","type":"company","lineage":["https://openalex.org/I74680897"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"R. Graham G. Russell","raw_affiliation_strings":["Botnar Research Centre, Nuffield Department of Orthopaedic Surgery, University of Oxford, Oxford, United Kingdom (A.J.R., P.A.H., R.G.G.R.); Bone Research Group, Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, United Kingdom (A.J.R., M.J.R.); Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee (C.M.E.); and Procter and Gamble Pharmaceuticals, Cincinnati, Ohio (F.H.E.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Botnar Research Centre, Nuffield Department of Orthopaedic Surgery, University of Oxford, Oxford, United Kingdom (A.J.R., P.A.H., R.G.G.R.); Bone Research Group, Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, United Kingdom (A.J.R., M.J.R.); Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee (C.M.E.); and Procter and Gamble Pharmaceuticals, Cincinnati, Ohio (F.H.E.)","institution_ids":["https://openalex.org/I195460627","https://openalex.org/I40120149","https://openalex.org/I74680897","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070859925","display_name":"Frank H. Ebetino","orcid":"https://orcid.org/0000-0002-9133-1360","observed_orcids":["https://orcid.org/0000-0002-9133-1360"]},"institutions":[{"id":"https://openalex.org/I195460627","display_name":"University of Aberdeen","ror":"https://ror.org/016476m91","country_code":"GB","type":"education","lineage":["https://openalex.org/I195460627"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I74680897","display_name":"Procter & Gamble (United States)","ror":"https://ror.org/04dkns738","country_code":"US","type":"company","lineage":["https://openalex.org/I74680897"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"F. Hal Ebetino","raw_affiliation_strings":["Botnar Research Centre, Nuffield Department of Orthopaedic Surgery, University of Oxford, Oxford, United Kingdom (A.J.R., P.A.H., R.G.G.R.); Bone Research Group, Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, United Kingdom (A.J.R., M.J.R.); Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee (C.M.E.); and Procter and Gamble Pharmaceuticals, Cincinnati, Ohio (F.H.E.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Botnar Research Centre, Nuffield Department of Orthopaedic Surgery, University of Oxford, Oxford, United Kingdom (A.J.R., P.A.H., R.G.G.R.); Bone Research Group, Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, United Kingdom (A.J.R., M.J.R.); Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee (C.M.E.); and Procter and Gamble Pharmaceuticals, Cincinnati, Ohio (F.H.E.)","institution_ids":["https://openalex.org/I195460627","https://openalex.org/I40120149","https://openalex.org/I74680897","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081312172","display_name":"Michael J. Rogers","orcid":"https://orcid.org/0000-0002-1818-9249","observed_orcids":["https://orcid.org/0000-0002-1818-9249"]},"institutions":[{"id":"https://openalex.org/I195460627","display_name":"University of Aberdeen","ror":"https://ror.org/016476m91","country_code":"GB","type":"education","lineage":["https://openalex.org/I195460627"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I74680897","display_name":"Procter & Gamble (United States)","ror":"https://ror.org/04dkns738","country_code":"US","type":"company","lineage":["https://openalex.org/I74680897"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Michael J. Rogers","raw_affiliation_strings":["Botnar Research Centre, Nuffield Department of Orthopaedic Surgery, University of Oxford, Oxford, United Kingdom (A.J.R., P.A.H., R.G.G.R.); Bone Research Group, Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, United Kingdom (A.J.R., M.J.R.); Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee (C.M.E.); and Procter and Gamble Pharmaceuticals, Cincinnati, Ohio (F.H.E.)","Applied Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Botnar Research Centre, Nuffield Department of Orthopaedic Surgery, University of Oxford, Oxford, United Kingdom (A.J.R., P.A.H., R.G.G.R.); Bone Research Group, Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, United Kingdom (A.J.R., M.J.R.); Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee (C.M.E.); and Procter and Gamble Pharmaceuticals, Cincinnati, Ohio (F.H.E.)","institution_ids":["https://openalex.org/I195460627","https://openalex.org/I40120149","https://openalex.org/I74680897","https://openalex.org/I901861585"]},{"raw_affiliation_string":"Applied Medicine","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033503332","display_name":"P A Hulley","orcid":"https://orcid.org/0000-0002-4994-2264","observed_orcids":["https://orcid.org/0000-0002-4994-2264"]},"institutions":[{"id":"https://openalex.org/I195460627","display_name":"University of Aberdeen","ror":"https://ror.org/016476m91","country_code":"GB","type":"education","lineage":["https://openalex.org/I195460627"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I74680897","display_name":"Procter & Gamble (United States)","ror":"https://ror.org/04dkns738","country_code":"US","type":"company","lineage":["https://openalex.org/I74680897"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Philippa A. Hulley","raw_affiliation_strings":["Botnar Research Centre, Nuffield Department of Orthopaedic Surgery, University of Oxford, Oxford, United Kingdom (A.J.R., P.A.H., R.G.G.R.); Bone Research Group, Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, United Kingdom (A.J.R., M.J.R.); Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee (C.M.E.); and Procter and Gamble Pharmaceuticals, Cincinnati, Ohio (F.H.E.)","Applied Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Botnar Research Centre, Nuffield Department of Orthopaedic Surgery, University of Oxford, Oxford, United Kingdom (A.J.R., P.A.H., R.G.G.R.); Bone Research Group, Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, United Kingdom (A.J.R., M.J.R.); Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee (C.M.E.); and Procter and Gamble Pharmaceuticals, Cincinnati, Ohio (F.H.E.)","institution_ids":["https://openalex.org/I195460627","https://openalex.org/I40120149","https://openalex.org/I74680897","https://openalex.org/I901861585"]},{"raw_affiliation_string":"Applied Medicine","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":null,"fwci":0.3523,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.63314984,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"322","issue":"1","first_page":"228","last_page":"235"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11308","display_name":"Sphingolipid Metabolism and Signaling","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lovastatin","display_name":"lovastatin","score":0.9959999918937683},{"id":"https://openalex.org/keywords/hmg-coa-reductase","display_name":"HMG-CoA reductase","score":0.9800000190734863},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9300000071525574},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.718999981880188},{"id":"https://openalex.org/keywords/mevalonate-pathway","display_name":"mevalonate pathway","score":0.8159999847412109},{"id":"https://openalex.org/keywords/protein-prenylation","display_name":"protein prenylation","score":0.9750000238418579},{"id":"https://openalex.org/keywords/rap1a","display_name":"Rap1A","score":0.7870000004768372},{"id":"https://openalex.org/keywords/phosphatidylcholine","display_name":"phosphatidylcholine","score":0.9150000214576721},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8370000123977661},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.4230000078678131}],"concepts":[{"id":"https://openalex.org/C2780940807","wikidata":"https://www.wikidata.org/wiki/Q417740","display_name":"Lovastatin","level":3,"score":0.9224905967712402},{"id":"https://openalex.org/C134651460","wikidata":"https://www.wikidata.org/wiki/Q3100717","display_name":"Reductase","level":3,"score":0.8149588108062744},{"id":"https://openalex.org/C104950815","wikidata":"https://www.wikidata.org/wiki/Q415607","display_name":"HMG-CoA reductase","level":4,"score":0.7811691164970398},{"id":"https://openalex.org/C2777320049","wikidata":"https://www.wikidata.org/wiki/Q2989497","display_name":"Hydroxymethylglutaryl-CoA reductase","level":5,"score":0.6821497678756714},{"id":"https://openalex.org/C2779123261","wikidata":"https://www.wikidata.org/wiki/Q407635","display_name":"Coenzyme A","level":4,"score":0.6172652840614319},{"id":"https://openalex.org/C2779982574","wikidata":"https://www.wikidata.org/wiki/Q14913010","display_name":"Mevalonate pathway","level":4,"score":0.5772349834442139},{"id":"https://openalex.org/C2776329913","wikidata":"https://www.wikidata.org/wiki/Q670131","display_name":"Simvastatin","level":2,"score":0.5381603240966797},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.5188854336738586},{"id":"https://openalex.org/C57790582","wikidata":"https://www.wikidata.org/wiki/Q901141","display_name":"Prenylation","level":3,"score":0.5146540403366089},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.47439220547676086},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.43713444471359253},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.39365270733833313},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.37194764614105225},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.3039954900741577},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.22158467769622803},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.13594776391983032}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004164","descriptor_name":"Diphosphonates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008148","descriptor_name":"Lovastatin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008798","descriptor_name":"Mevalonic Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008798","descriptor_name":"Mevalonic Acid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010713","descriptor_name":"Phosphatidylcholines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015536","descriptor_name":"Down-Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017368","descriptor_name":"Protein Prenylation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1124/jpet.106.116467","doi":"https://doi.org/10.1124/jpet.106.116467","is_oa":false,"landing_page_url":"https://doi.org/10.1124/jpet.106.116467","pdf_url":null,"source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},{"id":"pmid:17412884","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17412884","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of pharmacology and experimental therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2820734","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2820734","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"J Pharmacol Exp Ther","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:2820734","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2820734","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"J Pharmacol Exp Ther","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.6499999761581421,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2226598509","display_name":null,"funder_award_id":"16343","funder_id":"https://openalex.org/F4320327444","funder_display_name":"Versus Arthritis"}],"funders":[{"id":"https://openalex.org/F4320327444","display_name":"Versus Arthritis","ror":"https://ror.org/02jkpm469"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W575534482","https://openalex.org/W1479880028","https://openalex.org/W1525770659","https://openalex.org/W1550810733","https://openalex.org/W1567666856","https://openalex.org/W1603091820","https://openalex.org/W1679229316","https://openalex.org/W1860242155","https://openalex.org/W1944967894","https://openalex.org/W1966383174","https://openalex.org/W1971847276","https://openalex.org/W1972457509","https://openalex.org/W1987247016","https://openalex.org/W1995517837","https://openalex.org/W2002985493","https://openalex.org/W2014188685","https://openalex.org/W2017795729","https://openalex.org/W2020364703","https://openalex.org/W2022014446","https://openalex.org/W2022517233","https://openalex.org/W2025254322","https://openalex.org/W2033911923","https://openalex.org/W2037514587","https://openalex.org/W2039000781","https://openalex.org/W2039656447","https://openalex.org/W2049320871","https://openalex.org/W2058399581","https://openalex.org/W2093164779","https://openalex.org/W2095554275","https://openalex.org/W2107841008","https://openalex.org/W2112106048","https://openalex.org/W2113063129","https://openalex.org/W2117046467","https://openalex.org/W2127416705","https://openalex.org/W2145165269","https://openalex.org/W2158157260","https://openalex.org/W2165317664","https://openalex.org/W2279920289","https://openalex.org/W2322287023","https://openalex.org/W2414767959","https://openalex.org/W4245394911","https://openalex.org/W4388363524"],"related_works":["https://openalex.org/W7100511546","https://openalex.org/W2473340409","https://openalex.org/W2145165269","https://openalex.org/W2329250662","https://openalex.org/W2471344074","https://openalex.org/W2134673249","https://openalex.org/W2026048257","https://openalex.org/W2322800113","https://openalex.org/W1995517837","https://openalex.org/W2112106048"],"abstract_inverted_index":null,"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}